vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.

Vital Farms, Inc. is the larger business by last-quarter revenue ($213.6M vs $148.5M, roughly 1.4× OPKO HEALTH, INC.). Vital Farms, Inc. runs the higher net margin — 7.6% vs -21.1%, a 28.7% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs -19.2%). OPKO HEALTH, INC. produced more free cash flow last quarter ($-28.6M vs $-32.1M). Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".

OPK vs VITL — Head-to-Head

Bigger by revenue
VITL
VITL
1.4× larger
VITL
$213.6M
$148.5M
OPK
Growing faster (revenue YoY)
VITL
VITL
+47.8% gap
VITL
28.7%
-19.2%
OPK
Higher net margin
VITL
VITL
28.7% more per $
VITL
7.6%
-21.1%
OPK
More free cash flow
OPK
OPK
$3.6M more FCF
OPK
$-28.6M
$-32.1M
VITL
Faster 2-yr revenue CAGR
VITL
VITL
Annualised
VITL
20.2%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPK
OPK
VITL
VITL
Revenue
$148.5M
$213.6M
Net Profit
$-31.3M
$16.3M
Gross Margin
43.1%
35.8%
Operating Margin
-25.8%
10.0%
Net Margin
-21.1%
7.6%
Revenue YoY
-19.2%
28.7%
Net Profit YoY
-322.8%
54.3%
EPS (diluted)
$-0.04
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
VITL
VITL
Q4 25
$148.5M
$213.6M
Q3 25
$151.7M
$198.9M
Q2 25
$156.8M
$184.8M
Q1 25
$150.0M
$162.2M
Q4 24
$183.6M
$166.0M
Q3 24
$173.6M
$145.0M
Q2 24
$182.2M
$147.4M
Q1 24
$173.7M
$147.9M
Net Profit
OPK
OPK
VITL
VITL
Q4 25
$-31.3M
$16.3M
Q3 25
$21.6M
$16.4M
Q2 25
$-148.4M
$16.6M
Q1 25
$-67.6M
$16.9M
Q4 24
$14.0M
$10.6M
Q3 24
$24.9M
$7.4M
Q2 24
$-10.3M
$16.3M
Q1 24
$-81.8M
$19.0M
Gross Margin
OPK
OPK
VITL
VITL
Q4 25
43.1%
35.8%
Q3 25
32.9%
37.7%
Q2 25
31.5%
38.9%
Q1 25
28.4%
38.5%
Q4 24
46.1%
36.1%
Q3 24
23.1%
36.9%
Q2 24
28.4%
39.1%
Q1 24
24.2%
39.8%
Operating Margin
OPK
OPK
VITL
VITL
Q4 25
-25.8%
10.0%
Q3 25
31.7%
10.8%
Q2 25
-38.3%
12.9%
Q1 25
-44.8%
13.4%
Q4 24
-18.0%
7.8%
Q3 24
8.2%
6.4%
Q2 24
-33.9%
11.6%
Q1 24
-41.2%
16.3%
Net Margin
OPK
OPK
VITL
VITL
Q4 25
-21.1%
7.6%
Q3 25
14.3%
8.3%
Q2 25
-94.7%
9.0%
Q1 25
-45.1%
10.4%
Q4 24
7.6%
6.4%
Q3 24
14.3%
5.1%
Q2 24
-5.7%
11.1%
Q1 24
-47.1%
12.9%
EPS (diluted)
OPK
OPK
VITL
VITL
Q4 25
$-0.04
$0.35
Q3 25
$0.03
$0.36
Q2 25
$-0.19
$0.36
Q1 25
$-0.10
$0.37
Q4 24
$0.02
$0.23
Q3 24
$0.03
$0.16
Q2 24
$-0.01
$0.36
Q1 24
$-0.12
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
VITL
VITL
Cash + ST InvestmentsLiquidity on hand
$364.4M
$48.8M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$351.3M
Total Assets
$1.9B
$518.7M
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
VITL
VITL
Q4 25
$364.4M
$48.8M
Q3 25
$412.0M
$93.8M
Q2 25
$267.3M
$108.2M
Q1 25
$428.8M
$156.3M
Q4 24
$426.6M
$150.6M
Q3 24
$400.1M
$149.5M
Q2 24
$40.6M
$133.2M
Q1 24
$75.6M
$113.8M
Total Debt
OPK
OPK
VITL
VITL
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
OPK
OPK
VITL
VITL
Q4 25
$1.3B
$351.3M
Q3 25
$1.3B
$331.2M
Q2 25
$1.3B
$309.8M
Q1 25
$1.3B
$288.9M
Q4 24
$1.4B
$269.3M
Q3 24
$1.4B
$253.4M
Q2 24
$1.4B
$238.4M
Q1 24
$1.3B
$213.3M
Total Assets
OPK
OPK
VITL
VITL
Q4 25
$1.9B
$518.7M
Q3 25
$2.0B
$481.5M
Q2 25
$2.0B
$430.8M
Q1 25
$2.1B
$376.9M
Q4 24
$2.2B
$359.3M
Q3 24
$2.3B
$344.7M
Q2 24
$2.0B
$320.5M
Q1 24
$2.0B
$300.2M
Debt / Equity
OPK
OPK
VITL
VITL
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
VITL
VITL
Operating Cash FlowLast quarter
$-25.9M
$5.8M
Free Cash FlowOCF − Capex
$-28.6M
$-32.1M
FCF MarginFCF / Revenue
-19.3%
-15.1%
Capex IntensityCapex / Revenue
1.8%
17.8%
Cash ConversionOCF / Net Profit
0.35×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$-48.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
VITL
VITL
Q4 25
$-25.9M
$5.8M
Q3 25
$-34.6M
$23.4M
Q2 25
$-83.4M
$-761.0K
Q1 25
$-34.6M
$5.3M
Q4 24
$-44.4M
$14.8M
Q3 24
$-77.1M
$10.0M
Q2 24
$-26.4M
$16.1M
Q1 24
$-35.6M
$23.9M
Free Cash Flow
OPK
OPK
VITL
VITL
Q4 25
$-28.6M
$-32.1M
Q3 25
$-37.8M
$-10.6M
Q2 25
$-86.7M
$-7.6M
Q1 25
$-37.7M
$2.1M
Q4 24
$-49.8M
$-3.4M
Q3 24
$-85.0M
$6.4M
Q2 24
$-33.7M
$10.5M
Q1 24
$-40.0M
$22.6M
FCF Margin
OPK
OPK
VITL
VITL
Q4 25
-19.3%
-15.1%
Q3 25
-24.9%
-5.3%
Q2 25
-55.3%
-4.1%
Q1 25
-25.2%
1.3%
Q4 24
-27.1%
-2.0%
Q3 24
-49.0%
4.4%
Q2 24
-18.5%
7.2%
Q1 24
-23.0%
15.3%
Capex Intensity
OPK
OPK
VITL
VITL
Q4 25
1.8%
17.8%
Q3 25
2.1%
17.1%
Q2 25
2.1%
3.7%
Q1 25
2.1%
1.9%
Q4 24
2.9%
10.9%
Q3 24
4.6%
2.5%
Q2 24
4.0%
3.8%
Q1 24
2.6%
0.9%
Cash Conversion
OPK
OPK
VITL
VITL
Q4 25
0.35×
Q3 25
-1.60×
1.43×
Q2 25
-0.05×
Q1 25
0.31×
Q4 24
-3.17×
1.40×
Q3 24
-3.10×
1.34×
Q2 24
0.99×
Q1 24
1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

VITL
VITL

Eggs And Egg Related Products$205.8M96%
Butter And Butter Related Products$7.7M4%

Related Comparisons